Short-chain Pseudopeptide Bombesin Receptor Antagonists with Enhanced Binding Affinities for Pancreatic Acinar and Swiss 3T3 Cells Display Strong Antimitotic Activity-Reference-Cited by-同舟云学术

Short-chain Pseudopeptide Bombesin Receptor Antagonists with Enhanced Binding Affinities for Pancreatic Acinar and Swiss 3T3 Cells Display Strong Antimitotic Activity

Published:1989-09 Issue:25 Volume:264 Page:14691-14697
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Coy D H,Taylor J E,Jiang N Y,Kim S H,Wang L H,Huang S C,Moreau J P,Gardner J D,Jensen R T

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference32 articles.

1. Probing peptide backbone function in bombesin. A reduced peptide bond analogue with potent and specific receptor antagonist activity.

2. Effects of a Novel Bombesin Antagonist Analogue on Bombesin-Stimulated Gastric Acid Secretion and Growth Hormone Release in the Pentobarbital-Anesthetized Rat

3. [Leu13-ψ(CH2NH)Leu14]bombesin is a specific bombesin receptor antagonist in Swiss 3T3 cells

4. A novel bombesin receptor antagonist inhibits autocrine signals in a small cell lung carcinoma cell line

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GRPR-targeting radiotheranostics for breast cancer management;Frontiers in Medicine;2023-11-03

2. The Nonpeptide Agonist MK-5046 Functions As an Allosteric Agonist for the Bombesin Receptor Subtype-3;Journal of Pharmacology and Experimental Therapeutics;2022-05-29

3. Novel Positron-Emitting Radiopharmaceuticals;Nuclear Oncology;2022

4. Novel Positron-Emitting Radiopharmaceuticals;Nuclear Oncology;2022

5. Bombesin Receptor Family Activation and CNS/Neural Tumors: Review of Evidence Supporting Possible Role for Novel Targeted Therapy;Frontiers in Endocrinology;2021-09-01